Stress granules, P-bodies and cancer

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 7, 2015, Pages 861-870

  Anderson, Paul ^a,b   Kedersha, Nancy ^a,b   Ivanov, Pavel ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cancer; P body; Post transcriptional regulation; Stress granule; Stress response

Indexed keywords

ANTIINFECTIVE AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BORTEZOMIB; FLUOROURACIL; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; RNA; SODIUM SELENITE;

BREAST CANCER; CANCER CELL; CELL GRANULE; COLORECTAL CANCER; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; MYELOMA; NEOPLASM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STRESS; STRESS GRANULE; TUMOR MICROENVIRONMENT; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY;

ANIMALS; CYTOPLASMIC GRANULES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RNA, NEOPLASM;

EID: 84930823568     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2014.11.009     Document Type: Review

References (172)

1. Fasken M.B., Corbett A.H. Process or perish: quality control in mRNA biogenesis. Nat. Struct. Mol. Biol. 2005, 12:482-488.
2. Garneau N.L., Wilusz J., Wilusz C.J. The highways and byways of mRNA decay. Nat. Rev. Mol. Cell Biol. 2007, 8:113-126.
3. Schwanhausser B., Busse D., Li N., Dittmar G., Schuchhardt J., Wolf J., Chen W., Selbach M. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342.
4. Vogel C., Abreu Rde S., Ko D., Le S.Y., Shapiro B.A., Burns S.C., Sandhu D., Boutz D.R., Marcotte E.M., Penalva L.O. Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol. Syst. Biol. 2010, 6:400.
5. Gebauer F., Preiss T., Hentze M.W. From cis-regulatory elements to complex RNPs and back. Cold Spring Harb. Perspect. Biol. 2012, 4:a012245.
6. Ivanov P., Anderson P. Post-transcriptional regulatory networks in immunity. Immunol. Rev. 2013, 253:253-272.
7. Mitchell S.F., Parker R. Principles and properties of eukaryotic mRNPs. Mol. Cell 2014, 54:547-558.
8. Bloch D.B., Nobre R.A., Yang W.H. GW/P-bodies and autoimmune disease. Adv. Exp. Med. Biol. 2013, 768:61-70.
9. Buchan J.R. mRNP granules: assembly, function, and connections with disease. RNA Biol. 2014, 11.
10. Lloyd R.E. Regulation of stress granules and P-bodies during RNA virus infection. Wiley interdiscip. Rev. RNA 2013, 4:317-331.
11. Vanderweyde T., Youmans K., Liu-Yesucevitz L., Wolozin B. Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review. Gerontology 2013, 59:524-533.
12. Yamashita A., Chang T.C., Yamashita Y., Zhu W., Zhong Z., Chen C.Y., Shyu A.B. Concerted action of poly(A) nucleases and decapping enzyme in mammalian mRNA turnover. Nat. Struct. Mol. Biol. 2005, 12:1054-1063.
13. Chen C.Y., Shyu A.B. Mechanisms of deadenylation-dependent decay. Wiley Interdiscip. Rev. RNA 2011, 2:167-183.
14. Goldstrohm A.C., Wickens M. Multifunctional deadenylase complexes diversify mRNA control. Nat. Rev. Mol. Cell Biol. 2008, 9:337-344.
15. Wahle E., Winkler G.S. RNA decay machines: deadenylation by the Ccr4-not and Pan2-Pan3 complexes. Biochim. Biophys. Acta 2013, 1829:561-570.
16. Ling S.H., Qamra R., Song H. Structural and functional insights into eukaryotic mRNA decapping. Wiley Interdiscip. Rev. RNA 2011, 2:193-208.
17. Schoenberg D.R., Maquat L.E. Regulation of cytoplasmic mRNA decay. Nat. Rev. Genet. 2012, 13:246-259.
18. Anderson P., Kedersha N. RNA granules: post-transcriptional and epigenetic modulators of gene expression. Nat. Rev. Mol. Cell Biol. 2009, 10:430-436.
19. Bashkirov V.I., Scherthan H., Solinger J.A., Buerstedde J.M., Heyer W.D. A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates. J. Cell Biol. 1997, 136:761-773.
20. Ingelfinger D., Arndt-Jovin D.J., Luhrmann R., Achsel T. The human LSm1-7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 2002, 8:1489-1501.
21. van Dijk E., Cougot N., Meyer S., Babajko S., Wahle E., Seraphin B. Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 2002, 21:6915-6924.
22. Fenger-Gron M., Fillman C., Norrild B., Lykke-Andersen J. Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol. Cell 2005, 20:905-915.
23. Yu J.H., Yang W.H., Gulick T., Bloch K.D., Bloch D.B. Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 2005, 11:1795-1802.
24. Eulalio A., Behm-Ansmant I., Schweizer D., Izaurralde E. P-body formation is a consequence, not the cause, of RNA-mediated gene silencing. Mol. Cell. Biol. 2007, 27:3970-3981.
25. Scheller N., Resa-Infante P., de la Luna S., Galao R.P., Albrecht M., Kaestner L., Lipp P., Lengauer T., Meyerhans A., Diez J. Identification of PatL1, a human homolog to yeast P body component Pat1. Biochim. Biophys. Acta 2007, 1773:1786-1792.
26. Kedersha N., Stoecklin G., Ayodele M., Yacono P., Lykke-Andersen J., Fritzler M.J., Scheuner D., Kaufman R.J., Golan D.E., Anderson P. Stress granules and processing bodies are dynamically linked sites of mRNP remodeling. J. Cell Biol. 2005, 169:871-884.
27. Stoecklin G., Mayo T., Anderson P. ARE-mRNA degradation requires the 5'-3' decay pathway. EMBO Rep. 2006, 7:72-77.
28. Wilczynska A., Aigueperse C., Kress M., Dautry F., Weil D. The translational regulator CPEB1 provides a link between dcp1 bodies and stress granules. J. Cell Sci. 2005, 118:981-992.
29. Cougot N., Babajko S., Seraphin B. Cytoplasmic foci are sites of mRNA decay in human cells. J. Cell Biol. 2004, 165:31-40.
30. Zheng D., Ezzeddine N., Chen C.Y., Zhu W., He X., Shyu A.B. Deadenylation is prerequisite for P-body formation and mRNA decay in mammalian cells. J. Cell Biol. 2008, 182:89-101.
31. Ezzeddine N., Chang T.C., Zhu W., Yamashita A., Chen C.Y., Zhong Z., Yamashita Y., Zheng D., Shyu A.B. Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation. Mol. Cell. Biol. 2007, 27:7791-7801.
32. Durand S., Cougot N., Mahuteau-Betzer F., Nguyen C.H., Grierson D.S., Bertrand E., Tazi J., Lejeune F. Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies. J. Cell Biol. 2007, 178:1145-1160.
33. Sheth U., Parker R. Targeting of aberrant mRNAs to cytoplasmic processing bodies. Cell 2006, 125:1095-1109.
34. Unterholzner L., Izaurralde E. SMG7 acts as a molecular link between mRNA surveillance and mRNA decay. Mol. Cell 2004, 16:587-596.
35. Franks T.M., Lykke-Andersen J. TTP and BRF proteins nucleate processing body formation to silence mRNAs with AU-rich elements. Genes Dev. 2007, 21:719-735.
36. Stoecklin G., Anderson P. In a tight spot: ARE-mRNAs at processing bodies. Genes Dev. 2007, 21:627-631.
37. Eystathioy T., Jakymiw A., Chan E.K., Seraphin B., Cougot N., Fritzler M.J. The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA 2003, 9:1171-1173.
38. Liu J., Valencia-Sanchez M.A., Hannon G.J., Parker R. MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 2005, 7:719-723.
39. Sen G.L., Blau H.M. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell Biol. 2005, 7:633-636.
40. Andrei M.A., Ingelfinger D., Heintzmann R., Achsel T., Rivera-Pomar R., Luhrmann R. A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies. RNA 2005, 11:717-727.
41. Ferraiuolo M.A., Basak S., Dostie J., Murray E.L., Schoenberg D.R., Sonenberg N. A role for the eIF4E-binding protein 4E-T in P-body formation and mRNA decay. J. Cell Biol. 2005, 170:913-924.
42. Fujimura K., Kano F., Murata M. Identification of PCBP2, a facilitator of IRES-mediated translation, as a novel constituent of stress granules and processing bodies. RNA 2008, 14:425-431.
43. Aizer A., Brody Y., Ler L.W., Sonenberg N., Singer R.H., Shav-Tal Y. The dynamics of mammalian P body transport, assembly, and disassembly in vivo. Mol. Biol. Cell 2008, 19:4154-4166.
44. Leung A.K., Calabrese J.M., Sharp P.A. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:18125-18130.
45. Hu W., Petzold C., Coller J., Baker K.E. Nonsense-mediated mRNA decapping occurs on polyribosomes in Saccharomyces cerevisiae. Nat. Struct. Mol. Biol. 2010, 17:244-247.
46. Hu W., Sweet T.J., Chamnongpol S., Baker K.E., Coller J. Co-translational mRNA decay in Saccharomyces cerevisiae. Nature 2009, 461:225-229.
47. Aizer A., Kalo A., Kafri P., Shraga A., Ben-Yishay R., Jacob A., Kinor N., Shav-Tal Y. Quantifying mRNA targeting to P-bodies in living human cells reveals their dual role in mRNA decay and storage. J. Cell Sci. 2014, 127:4443-4456.
48. Anderson P., Kedersha N. Stress granules. Curr. Biol. 2009, 19:R397-R398.
49. Ivanov P., Kedersha N., Anderson P. Stress puts TIA on TOP. Genes Dev. 2011, 25:2119-2124.
50. Kedersha N., Ivanov P., Anderson P. Stress granules and cell signaling: more than just a passing phase?. Trends Biochem. Sci. 2013, 38:494-506.
51. Kedersha N.L., Gupta M., Li W., Miller I., Anderson P. RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules. J. Cell Biol. 1999, 147:1431-1442.
52. Holcik M., Sonenberg N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 2005, 6:318-327.
53. Jackson R.J., Hellen C.U., Pestova T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 2010, 11:113-127.
54. Pestova T.V., Kolupaeva V.G., Lomakin I.B., Pilipenko E.V., Shatsky I.N., Agol V.I., Hellen C.U. Molecular mechanisms of translation initiation in eukaryotes. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:7029-7036.
55. Kedersha N., Chen S., Gilks N., Li W., Miller I.J., Stahl J., Anderson P. Evidence that ternary complex (eIF2-GTP-tRNA(i)(Met))-deficient preinitiation complexes are core constituents of mammalian stress granules. Mol. Biol. Cell 2002, 13:195-210.
56. Kedersha N., Cho M.R., Li W., Yacono P.W., Chen S., Gilks N., Golan D.E., Anderson P. Dynamic shuttling of TIA-1 accompanies the recruitment of mRNA to mammalian stress granules. J. Cell Biol. 2000, 151:1257-1268.
57. Tourriere H., Chebli K., Zekri L., Courselaud B., Blanchard J.M., Bertrand E., Tazi J. The RasGAP-associated endoribonuclease G3BP assembles stress granules. J. Cell Biol. 2003, 160:823-831.
58. Gilks N., Kedersha N., Ayodele M., Shen L., Stoecklin G., Dember L.M., Anderson P. Stress granule assembly is mediated by prion-like aggregation of TIA-1. Mol. Biol. Cell 2004, 15:5383-5398.
59. Mollet S., Cougot N., Wilczynska A., Dautry F., Kress M., Bertrand E., Weil D. Translationally repressed mRNA transiently cycles through stress granules during stress. Mol. Biol. Cell 2008, 19:4469-4479.
60. Bhattacharyya S.N., Habermacher R., Martine U., Closs E.I., Filipowicz W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 2006, 125:1111-1124.
61. Gallois-Montbrun S., Kramer B., Swanson C.M., Byers H., Lynham S., Ward M., Malim M.H. Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol. 2007, 81:2165-2178.
62. Pare J.M., Tahbaz N., Lopez-Orozco J., LaPointe P., Lasko P., Hobman T.C. Hsp90 regulates the function of argonaute 2 and its recruitment to stress granules and P-bodies. Mol. Biol. Cell 2009, 20:3273-3284.
63. Gallouzi I.E., Brennan C.M., Stenberg M.G., Swanson M.S., Eversole A., Maizels N., Steitz J.A. HuR binding to cytoplasmic mRNA is perturbed by heat shock. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:3073-3078.
64. Yang W.H., Bloch D.B. Probing the mRNA processing body using protein macroarrays and "autoantigenomics". RNA 2007, 13:704-712.
65. Stoecklin G., Stubbs T., Kedersha N., Wax S., Rigby W.F., Blackwell T.K., Anderson P. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 2004, 23:1313-1324.
66. Ohn T., Kedersha N., Hickman T., Tisdale S., Anderson P. A functional RNAi screen links O-GlcNAc modification of ribosomal proteins to stress granule and processing body assembly. Nat. Cell Biol. 2008, 10:1224-1231.
67. Serman A., Le Roy F., Aigueperse C., Kress M., Dautry F., Weil D. GW body disassembly triggered by siRNAs independently of their silencing activity. Nucleic Acids Res. 2007, 35:4715-4727.
68. Decker C.J., Parker R. P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harb. Perspect. Biol. 2012, 4:a012286.
69. Kulkarni M., Ozgur S., Stoecklin G. On track with P-bodies. Biochem. Soc. Trans. 2010, 38:242-251.
70. Stoecklin G., Kedersha N. Relationship of GW/P-bodies with stress granules. Adv. Exp. Med. Biol. 2013, 768:197-211.
71. Anderson P., Kedersha N. Stress granules: the Tao of RNA triage. Trends Biochem. Sci. 2008, 33:141-150.
72. Baird T.D., Wek R.C. Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv. Nutr. 2012, 3:307-321.
73. Donnelly N., Gorman A.M., Gupta S., Samali A. The eIF2alpha kinases: their structures and functions. Cell. Mol. Life Sci. 2013, 70:3493-3511.
74. Wek S.A., Zhu S., Wek R.C. The histidyl-tRNA synthetase-related sequence in the eIF-2 alpha protein kinase GCN2 interacts with tRNA and is required for activation in response to starvation for different amino acids. Mol. Cell. Biol. 1995, 15:4497-4506.
75. McEwen E., Kedersha N., Song B., Scheuner D., Gilks N., Han A., Chen J.J., Anderson P., Kaufman R.J. Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure. J. Biol. Chem. 2005, 280:16925-16933.
76. Harding H.P., Novoa I., Zhang Y., Zeng H., Wek R., Schapira M., Ron D. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol. Cell 2000, 6:1099-1108.
77. Harding H.P., Zhang Y., Bertolotti A., Zeng H., Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell 2000, 5:897-904.
78. Srivastava S.P., Kumar K.U., Kaufman R.J. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J. Biol. Chem. 1998, 273:2416-2423.
79. Ackerman D., Simon M.C. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. Trends Cell Biol. 2014, 24:472-478.
80. Clarke H.J., Chambers J.E., Liniker E., Marciniak S.J. Endoplasmic reticulum stress in malignancy. Cancer Cell 2014, 25:563-573.
81. Porporato P.E., Dhup S., Dadhich R.K., Copetti T., Sonveaux P. Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front. Pharmacol. 2011, 2:49.
82. Gorrini C., Harris I.S., Mak T.W. Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 2013, 12:931-947.
83. Costa A., Scholer-Dahirel A., Mechta-Grigoriou F. The role of reactive oxygen species and metabolism on cancer cells and their microenvironment. Semin. Cancer Biol. 2014, 25:23-32.
84. Wall S.B., Oh J.Y., Diers A.R., Landar A. Oxidative modification of proteins: an emerging mechanism of cell signaling. Front. Physiol. 2012, 3:369.
85. Shen S., Li X.F., Cullen W.R., Weinfeld M., Le X.C. Arsenic binding to proteins. Chem. Rev. 2013, 113:7769-7792.
86. Kwon S., Zhang Y., Matthias P. The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes Dev. 2007, 21:3381-3394.
87. Arimoto K., Fukuda H., Imajoh-Ohmi S., Saito H., Takekawa M. Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nat. Cell Biol. 2008, 10:1324-1332.
88. Kim W.J., Back S.H., Kim V., Ryu I., Jang S.K. Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions. Mol. Cell. Biol. 2005, 25:2450-2462.
89. Moeller B.J., Cao Y., Li C.Y., Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 2004, 5:429-441.
90. Emara M.M., Fujimura K., Sciaranghella D., Ivanova V., Ivanov P., Anderson P. Hydrogen peroxide induces stress granule formation independent of eIF2alpha phosphorylation. Biochem. Biophys. Res. Commun. 2012, 423:763-769.
91. Fujimura K., Sasaki A.T., Anderson P. Selenite targets eIF4E-binding protein-1 to inhibit translation initiation and induce the assembly of non-canonical stress granules. Nucleic Acids Res. 2012, 40:8099-8110.
92. Takahashi M., Higuchi M., Matsuki H., Yoshita M., Ohsawa T., Oie M., Fujii M. Stress granules inhibit apoptosis by reducing reactive oxygen species production. Mol. Cell. Biol. 2013, 33:815-829.
93. Cande C., Vahsen N., Metivier D., Tourriere H., Chebli K., Garrido C., Tazi J., Kroemer G. Regulation of cytoplasmic stress granules by apoptosis-inducing factor. J. Cell Sci. 2004, 117:4461-4468.
94. Ortega A.D., Willers I.M., Sala S., Cuezva J.M. Human G3BP1 interacts with beta-F1-ATPase mRNA and inhibits its translation. J. Cell Sci. 2010, 123:2685-2696.
95. Liu J., Xia H., Kim M., Xu L., Li Y., Zhang L., Cai Y., Norberg H.V., Zhang T., Furuya T., Jin M., Zhu Z., Wang H., Yu J., Li Y., Hao Y., Choi A., Ke H., Ma D., Yuan J. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 2011, 147:223-234.
96. Zhang H., Shao R.G. G3BP: a promising target for cancer therapy. Yao Xue Xue Bao 2010, 45:945-951.
97. Lin Z., Yang H., Tan C., Li J., Liu Z., Quan Q., Kong S., Ye J., Gao B., Fang D. USP10 antagonizes c-Myc transcriptional activation through SIRT6 stabilization to suppress tumor formation. Cell Rep. 2013, 5:1639-1649.
98. Fournier M.J., Gareau C., Mazroui R. The chemotherapeutic agent bortezomib induces the formation of stress granules. Cancer Cell Int. 2010, 10:12.
99. Mazroui R., Di Marco S., Kaufman R.J., Gallouzi I.E. Inhibition of the ubiquitin-proteasome system induces stress granule formation. Mol. Biol. Cell 2007, 18:2603-2618.
100. Mazroui R., Sukarieh R., Bordeleau M.E., Kaufman R.J., Northcote P., Tanaka J., Gallouzi I., Pelletier J. Inhibition of ribosome recruitment induces stress granule formation independently of eukaryotic initiation factor 2alpha phosphorylation. Mol. Biol. Cell 2006, 17:4212-4219.
101. Gareau C., Fournier M.J., Filion C., Coudert L., Martel D., Labelle Y., Mazroui R. p21(WAF1/CIP1) upregulation through the stress granule-associated protein CUGBP1 confers resistance to bortezomib-mediated apoptosis. PLoS One 2011, 6:e20254.
102. Kaehler C., Isensee J., Hucho T., Lehrach H., Krobitsch S. 5-Fluorouracil affects assembly of stress granules based on RNA incorporation. Nucleic Acids Res. 2014, 42:6436-6447.
103. Longley D.B., Harkin D.P., Johnston P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer 2003, 3:330-338.
104. Garcia M.A., Carrasco E., Aguilera M., Alvarez P., Rivas C., Campos J.M., Prados J.C., Calleja M.A., Esteban M., Marchal J.A., Aranega A. The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells. PLoS One 2011, 6:e23887.
105. Saito K., Kondo E., Matsushita M. MicroRNA 130 family regulates the hypoxia response signal through the P-body protein DDX6. Nucleic Acids Res. 2011, 39:6086-6099.
106. Kim W.J., Kim J.H., Jang S.K. Anti-inflammatory lipid mediator 15d-PGJ2 inhibits translation through inactivation of eIF4A. EMBO J. 2007, 26:5020-5032.
107. Shin S.W., Seo C.Y., Han H., Han J.Y., Jeong J.S., Kwak J.Y., Park J.I. 15d-PGJ2 induces apoptosis by reactive oxygen species-mediated inactivation of Akt in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin. Cancer Res. 2009, 15:5414-5425.
108. Bordeleau M.E., Matthews J., Wojnar J.M., Lindqvist L., Novac O., Jankowsky E., Sonenberg N., Northcote P., Teesdale-Spittle P., Pelletier J. Stimulation of mammalian translation initiation factor eIF4A activity by a small molecule inhibitor of eukaryotic translation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:10460-10465.
109. Low W.K., Dang Y., Schneider-Poetsch T., Shi Z., Choi N.S., Merrick W.C., Romo D., Liu J.O. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A. Mol. Cell 2005, 20:709-722.
110. Bordeleau M.E., Mori A., Oberer M., Lindqvist L., Chard L.S., Higa T., Belsham G.J., Wagner G., Tanaka J., Pelletier J. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat. Chem. Biol. 2006, 2:213-220.
111. Bordeleau M.E., Robert F., Gerard B., Lindqvist L., Chen S.M., Wendel H.G., Brem B., Greger H., Lowe S.W., Porco J.A., Pelletier J. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J. Clin. Invest. 2008, 118:2651-2660.
112. Bordeleau M.E., Cencic R., Lindqvist L., Oberer M., Northcote P., Wagner G., Pelletier J. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation. Chem. Biol. 2006, 13:1287-1295.
113. Dang Y., Kedersha N., Low W.K., Romo D., Gorospe M., Kaufman R., Anderson P., Liu J.O. Eukaryotic initiation factor 2alpha-independent pathway of stress granule induction by the natural product pateamine A. J. Biol. Chem. 2006, 281:32870-32878.
114. Hood K.A., West L.M., Northcote P.T., Berridge M.V., Miller J.H. Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine. Apoptosis 2001, 6:207-219.
115. Kuznetsov G., Xu Q., Rudolph-Owen L., Tendyke K., Liu J., Towle M., Zhao N., Marsh J., Agoulnik S., Twine N., Parent L., Chen Z., Shie J.L., Jiang Y., Zhang H., Du H., Boivin R., Wang Y., Romo D., Littlefield B.A. Potent in vitro and in vivo anticancer activities of des-methyl, des-amino pateamine A, a synthetic analogue of marine natural product pateamine A. Mol. Cancer Ther. 2009, 8:1250-1260.
116. Chambers J.M., Lindqvist L.M., Webb A., Huang D.C., Savage G.P., Rizzacasa M.A. Synthesis of biotinylated episilvestrol: highly selective targeting of the translation factors eIF4AI/II. Org. Lett. 2013, 15:1406-1409.
117. Cencic R., Carrier M., Galicia-Vazquez G., Bordeleau M.E., Sukarieh R., Bourdeau A., Brem B., Teodoro J.G., Greger H., Tremblay M.L., Porco J.A., Pelletier J. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. PLoS One 2009, 4:e5223.
118. Kogure T., Kinghorn A.D., Yan I., Bolon B., Lucas D.M., Grever M.R., Patel T. Therapeutic potential of the translation inhibitor silvestrol in hepatocellular cancer. PLoS One 2013, 8:e76136.
119. Sun Y., Atas E., Lindqvist L.M., Sonenberg N., Pelletier J., Meller A. Single-molecule kinetics of the eukaryotic initiation factor 4AI upon RNA unwinding. Structure 2014, 22:941-948.
120. Cencic R., Robert F., Galicia-Vazquez G., Malina A., Ravindar K., Somaiah R., Pierre P., Tanaka J., Deslongchamps P., Pelletier J. Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A. Blood Cancer J. 2013, 3:e128.
121. Tsumuraya T., Ishikawa C., Machijima Y., Nakachi S., Senba M., Tanaka J., Mori N. Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia. Biochem. Pharmacol. 2011, 81:713-722.
122. Laplante M., Sabatini D.M. mTOR signaling in growth control and disease. Cell 2012, 149:274-293.
123. Laplante M., Sabatini D.M. Regulation of mTORC1 and its impact on gene expression at a glance. J. Cell Sci. 2013, 126:1713-1719.
124. Mendoza M.C., Er E.E., Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 2011, 36:320-328.
125. Wippich F., Bodenmiller B., Trajkovska M.G., Wanka S., Aebersold R., Pelkmans L. Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling. Cell 2013, 152:791-805.
126. Yoshida S., Hong S., Suzuki T., Nada S., Mannan A.M., Wang J., Okada M., Guan K.L., Inoki K. Redox regulates mammalian target of rapamycin complex 1 (mTORC1) activity by modulating the TSC1/TSC2-Rheb GTPase pathway. J. Biol. Chem. 2011, 286:32651-32660.
127. Thedieck K., Holzwarth B., Prentzell M.T., Boehlke C., Klasener K., Ruf S., Sonntag A.G., Maerz L., Grellscheid S.N., Kremmer E., Nitschke R., Kuehn E.W., Jonker J.W., Groen A.K., Reth M., Hall M.N., Baumeister R. Inhibition of mTORC1 by astrin and stress granules prevents apoptosis in cancer cells. Cell 2013, 154:859-874.
128. Damgaard C.K., Lykke-Andersen J. Translational coregulation of 5'TOP mRNAs by TIA-1 and TIAR. Genes Dev. 2011, 25:2057-2068.
129. Meyuhas O., Avni D., Shama S. Translational control of ribosomal protein mRNAs in eukaryotes 1996, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
130. Polunovsky V.A., Bitterman P.B. The cap-dependent translation apparatus integrates and amplifies cancer pathways. RNA Biol. 2006, 3:10-17.
131. Sonenberg N., Hinnebusch A.G. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009, 136:731-745.
132. Wendel H.G., De Stanchina E., Fridman J.S., Malina A., Ray S., Kogan S., Cordon-Cardo C., Pelletier J., Lowe S.W. Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy. Nature 2004, 428:332-337.
133. Wendel H.G., Silva R.L., Malina A., Mills J.R., Zhu H., Ueda T., Watanabe-Fukunaga R., Fukunaga R., Teruya-Feldstein J., Pelletier J., Lowe S.W. Dissecting eIF4E action in tumorigenesis. Genes Dev. 2007, 21:3232-3237.
134. Adams D.R., Ron D., Kiely P.A. RACK1, A multifaceted scaffolding protein: structure and function. Cell Commun. Signal. 2011, 9:22.
135. Gandin V., Senft D., Topisirovic I., Ronai Z.A. RACK1 function in cell motility and protein synthesis. Genes Cancer 2013, 4:369-377.
136. Li J.J., Xie D. RACK1, a versatile hub in cancer. Oncogene 2014, 10.1038/onc.2014.127.
137. Carrick D.M., Blackshear P.J. Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines. Arch. Biochem. Biophys. 2007, 462:278-285.
138. Brennan S.E., Kuwano Y., Alkharouf N., Blackshear P.J., Gorospe M., Wilson G.M. The mRNA-destabilizing protein tristetraprolin is suppressed in many cancers, altering tumorigenic phenotypes and patient prognosis. Cancer Res. 2009, 69:5168-5176.
139. Stoecklin G., Gross B., Ming X.F., Moroni C. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA. Oncogene 2003, 22:3554-3561.
140. Gebeshuber C.A., Zatloukal K., Martinez J. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. EMBO Rep. 2009, 10:400-405.
141. Rounbehler R.J., Fallahi M., Yang C., Steeves M.A., Li W., Doherty J.R., Schaub F.X., Sanduja S., Dixon D.A., Blackshear P.J., Cleveland J.L. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state. Cell 2012, 150:563-574.
142. Lopez de Silanes I., Fan J., Yang X., Zonderman A.B., Potapova O., Pizer E.S., Gorospe M. Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 2003, 22:7146-7154.
143. Abdelmohsen K., Srikantan S., Kuwano Y., Gorospe M. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:20297-20302.
144. Abdelmohsen K., Tominaga-Yamanaka K., Srikantan S., Yoon J.H., Kang M.J., Gorospe M. RNA-binding protein AUF1 represses Dicer expression. Nucleic Acids Res. 2012, 40(22):11531-11544.
145. Mihailovich M., Militti C., Gabaldon T., Gebauer F. Eukaryotic cold shock domain proteins: highly versatile regulators of gene expression. Bioessays 2010, 32:109-118.
146. Balzer E., Moss E.G. Localization of the developmental timing regulator Lin28 to mRNP complexes, P-bodies and stress granules. RNA Biol. 2007, 4:16-25.
147. Eliseeva I.A., Kim E.R., Guryanov S.G., Ovchinnikov L.P., Lyabin D.N. Y-box-binding protein 1 (YB-1) and its functions. Biochemistry 2011, 76:1402-1433.
148. Zhou J., Ng S.B., Chng W.J. LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells. Int. J. Biochem. Cell Biol. 2013, 45:973-978.
149. Shyh-Chang N., Daley G.Q. Lin28: primal regulator of growth and metabolism in stem cells. Cell Stem Cell 2013, 12:395-406.
150. Viswanathan S.R., Powers J.T., Einhorn W., Hoshida Y., Ng T.L., Toffanin S., O'Sullivan M., Lu J., Phillips L.A., Lockhart V.L., Shah S.P., Tanwar P.S., Mermel C.H., Beroukhim R., Azam M., Teixeira J., Meyerson M., Hughes T.P., Llovet J.M., Radich J., Mullighan C.G., Golub T.R., Sorensen P.H., Daley G.Q. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 2009, 41:843-848.
151. Evdokimova V., Tognon C., Ng T., Ruzanov P., Melnyk N., Fink D., Sorokin A., Ovchinnikov L.P., Davicioni E., Triche T.J., Sorensen P.H. Translational activation of snail1 and other developmentally regulated transcription factors by YB-1 promotes an epithelial-mesenchymal transition. Cancer Cell 2009, 15:402-415.
152. Pizzo E., Sarcinelli C., Sheng J., Fusco S., Formiggini F., Netti P., Yu W., D'Alessio G., Hu G.F. Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival. J. Cell Sci. 2013, 126:4308-4319.
153. Li S., Hu G.F. Emerging role of angiogenin in stress response and cell survival under adverse conditions. J. Cell. Physiol. 2012, 227:2822-2826.
154. Li S., Hu G.F. Angiogenin-mediated rRNA transcription in cancer and neurodegeneration. Int. J. Biochem. Mol. Biol. 2010, 1:26-35.
155. Saikia M., Krokowski D., Guan B.J., Ivanov P., Parisien M., Hu G.F., Anderson P., Pan T., Hatzoglou M. Genome-wide identification and quantitative analysis of cleaved tRNA fragments induced by cellular stress. J. Biol. Chem. 2012, 287:42708-42725.
156. Yamasaki S., Ivanov P., Hu G.F., Anderson P. Angiogenin cleaves tRNA and promotes stress-induced translational repression. J. Cell Biol. 2009, 185:35-42.
157. Anderson P., Ivanov P. tRNA fragments in human health and disease. FEBS Lett. 2014, 588:4297-4304.
158. Emara M.M., Ivanov P., Hickman T., Dawra N., Tisdale S., Kedersha N., Hu G.F., Anderson P. Angiogenin-induced tRNA-derived stress-induced RNAs promote stress-induced stress granule assembly. J. Biol. Chem. 2010, 285:10959-10968.
159. Ivanov P., Emara M.M., Villen J., Gygi S.P., Anderson P. Angiogenin-induced tRNA fragments inhibit translation initiation. Mol. Cell 2011, 43:613-623.
160. Fu P., Chen J., Tian Y., Watkins T., Cui X., Zhao B. Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor. Cancer Gene Ther. 2005, 12:268-275.
161. Pan X., Xiong D., Yao X., Xin Y., Zhang L., Chen J. Up-regulating ribonuclease inhibitor inhibited epithelial-to-mesenchymal transition and metastasis in murine melanoma cells. Int. J. Biochem. Cell Biol. 2012, 44:998-1008.
162. Yao X., Li D., Xiong D.M., Li L., Jiang R., Chen J.X. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells. Cell Tissue Res. 2013, 353:409-423.
163. Li C.H., Ohn T., Ivanov P., Tisdale S., Anderson P. eIF5A promotes translation elongation, polysome disassembly and stress granule assembly. PLoS ONE 2010, 5:e9942.
164. Fujimura K., Wright T., Strnadel J., Kaushal S., Metildi C., Lowy A.M., Bouvet M., Kelber J.A., Klemke R.L. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Cancer Res. 2014, 74:6671-6681.
165. Hilliker A., Gao Z., Jankowsky E., Parker R. The DEAD-box protein Ded1 modulates translation by the formation and resolution of an eIF4F-mRNA complex. Mol. Cell 2011, 43:962-972.
166. Shih J.W., Wang W.T., Tsai T.Y., Kuo C.Y., Li H.K., Wu Lee Y.H. Critical roles of RNA helicase DDX3 and its interactions with eIF4E/PABP1 in stress granule assembly and stress response. Biochem. J. 2012, 441:119-129.
167. Bol G.M., Raman V., van der Groep P., Vermeulen J.F., Patel A.H., van der Wall E., van Diest P.J. Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer. PLoS One 2013, 8:e63548.
168. Chen H.H., Yu H.I., Cho W.C., Tarn W.Y. DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway. Oncogene 2014, 10.1038/onc.2014.190.
169. Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 2009, 10:94-108.
170. Ha M., Kim V.N. Regulation of microRNA biogenesis. Nat. Rev. Mol. Cell Biol. 2014, 15:509-524.
171. Hayes J., Peruzzi P.P., Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol. Med. 2014, 20:460-469.
172. Palanichamy J.K., Rao D.S. miRNA dysregulation in cancer: towards a mechanistic understanding. Front. Genet. 2014, 5:54.